Management of Severe Neuropathic Cancer Pain: An Illustrative Case and Review

American Journal of Hospice and Palliative Medicine

Volumn 30, Issue 1, 2013, Pages 83-90

  Connolly, Irene ^a   Zaleon, Carolyn ^b,c   Montagnini, Marcos ^b,c,d  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

adjuvant analgesics; cancer; methadone; neuropathic pain; opioids; palliative care

Indexed keywords

ANTICONVULSIVE AGENT; METHADONE; NARCOTIC ANALGESIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGED; ANALGESIA; ARTICLE; CASE REPORT; DRUG COMBINATION; HEAD AND NECK TUMOR; HUMAN; MALE; METHODOLOGY; NEURALGIA;

AGED; ANALGESICS, OPIOID; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; METHADONE; NEURALGIA; PAIN MANAGEMENT; SEROTONIN UPTAKE INHIBITORS;

EID: 84871651908     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909112443586     Document Type: Article

References (59)

1. Morley JS,Makin MK.The use of methadone in cancer pain poorly responsive to other opioids.Pain Rev. 1998;5 ((1)): 51-58.
2. Gilron I,Watson CPN,Cahill CM,Moulin DE.Neuropathic pain: a practical guide for the clinician.CMAJ. 2006;175 (3): 265-275.
3. Grond S,Redbruch L,Meuser T,Sabatowski R,Loick G,Lehmann KA.Assessment and treatment of neuropathic cancer pain following WHO guidelines.Pain. 1999;79 (1): 15-20.
4. Schmader KE.Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy.Clin J Pain. 2002;18 (6): 350-354.
5. Talmi YP,Waller A,Bercovici M, et al.Pain experienced by patients with terminal head and neck carcinoma.Cancer. 1997;80 (6): 1117-1123.
6. Grond S,Zech D,Diefenbach C,Radbruch L,Lehmann KA.Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service.Pain. 1996;64 (1): 107-114.
7. Baron R.Mechanisms of disease: neuropathic pain-a clinical perspective.Nat Clin Pract Neurol. 2006;2 (2): 95-106.
8. Baron R,Binder A,Wasner G.Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.Lancet Neurol. 2010;9 (8): 807-819.
9. Dworkin RH,O'Connor AB,Audette J, et al.Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.Mayo Clin Proc. 2010;85 (3 suppl): S3-S14.
10. Davis MP.What is new in neuropathic pain?.Support Care Cancer. 2007;15 (4): 363-372.
11. Rowbotham M,Harden N,Stacey B,Bernstein P,Magnus-Miller L.Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.JAMA. 1998;280 (21): 1837-1842.
12. Tai Z,Kirshblum S,Chen B,Millis S,Jonhston M,DeLisa JA.Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial.J Spinal Cord Med. 2002;25 (2): 100-105.
13. Serpell MG.Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial.Pain. 2002;99 (3): 557-566.
14. Gordh TE,Stubhaug A,Jensen TS, et al.Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study.Pain. 2008;138 (2): 255-266.
15. McDonald AA,Portenoy RK.How to use antidepressants and anticonvulsants as adjuvant analgesics in the treatment of neuropathic cancer pain.J Support Oncology. 2006;4 (1): 43-52.
16. Keskinbora K,Pekel AF,Aydinli I.Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial.J Pain Symptom Manage. 2007;34 (2): 183-189.
17. Caraceni A,Zecca E,Bonezzi C, et al.Gapabentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group.J Clin Oncol. 2004;22 (14): 2909-2917.
18. Tölle T,Freynhagen R,Versavel M,Trostmann U,Young JP.Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.Eur J Pain. 2008;12 (2): 203-213.
19. Richter RW,Portenoy R,Sharma U,LaMoreaux L,Bockbrader H,Knapp LE.Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.J Pain. 2005;6 (4): 253-260.
20. Sabatowski R,Galvez R,Cherry DA, et al.Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial.Pain. 2004;109 (1-2): 26-35.
21. Dworkin RH,Corbin AE,Young JP, et al.Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.Neurology. 2003;60 (8): 1274-1283.
22. Vranken JH,Dijkgraaf MG,Kruis MR,van der Vegt MH,Hollmann MW,Heesen M.Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen.Pain. 2008;136 (1-2): 150-157.
23. Sindrup SH,Otto M,Finnerup NB,Jensen TS.Antidepressants in the treatment of neuropathic pain.Basic Clin Pharmacol Toxicol. 2005;96 (6): 399-409.
24. Saarto T,Wiffen PJ.Antidepressants for neuropathic pain.Cochrane Database Syst Rev. 2007; (2): CD005454.
25. Gilron I,Bailey JM,Dongsheng T,Holden RR,Jackson AC,Houlden RL.Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.Lancet. 2009;374 (9697): 1252-1261.
26. Rowbotham MC,Goli V,Kunz NR,Lei D.Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.Pain. 2004;110 (3): 697-706.
27. Sindrup SH,Bach FW,Madsen C,Gram LF,Jensen TS.Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.Neurology. 2003;60 (8): 1284-1289.
28. Tasmuth T,Hartel B,Kalso E.Venlafaxine in neuropathic pain following treatment of breast cancer.Eur J Pain. 2002;6 (1): 17-24.
29. Grothe Dr,Scheckner B,Albano D.Treatment of pain syndromes with venlafaxine.Pharmacotherapy. 2004;24 (5): 621-629.
30. Kajdasz DK,Iyengar S,Desaiah D, et al.Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.Clin Ther. 2007;29 (suppl): S2536-S2546.
31. Raskin J,Pritchett YL,Wang F, et al.A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.Pain Med. 2005;6 (5): 346-356.
32. Meier T,Wasner G,Faust M, et al.Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study.Pain. 2003;106 (1-2): 151-158.
33. Binder A,Bruxelle J,Rogers P,Hans G,Boesl I,Baron R.Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.Clin Drug Investig. 2009;29 (6): 393-408.
34. Baron R,Mayoral V,Leijon G,Binder A,Steigerwald I,Serpell M.Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.Clin Drug Investig. 2009;29 (4): 231-241.
35. Gammaitoni AR,Davis MW.Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.Ann Pharmacother. 2002;36 (2): 236-240.
36. Kong VKF,Irwin MG.Adjuvant analgesics in neuropathic pain.Eur J Anaesthesiol. 2009;26 (2): 96-100.
37. Baron R,Janig WPharmacology of Pain. Beaulieu PLussier DPorreca FDickenson AH, ed. Seattle, WA: IASP Press; 2010:347-381.
38. Moulin DE,Clark AJ,Gilron I, et al.Pharmacological management of chronic neuropathic pain-Consensus statement and guidelines from the canadian pain society.Pain Res Manage. 2007;12 (1): 13-21.
39. Nunez Olarte JM.Oxycodone and the callenge of neuropathic cancer pain; a review.Oncology. 2008;74 (1 suppl): S83-S90.
40. Gilron I,Bailey JM,Tu D,Holden RR,Weaver DF,Houlden RL.Morphine, gabapentin, or their combination for neuropathic pain.N Engl J Med. 2005;352 (13): 1324-1334.
41. Hanna M,O'Brien C,Wilson MC.Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.Eur J Pain. 2008;12 (6): 804-813.
42. Gatti A,Sabato AF,Occhioni R,Baldeshi GC,Reale C.Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study.Eur Neurol. 2009;61 (3): 129-137.
43. Davis M, Quigley C, Opioids in Cancer Pain. 2nd ed. New York, NY: Oxford University Press; 2009:211-243.Davis M Glare PQuigley CHardy JR, ed. New York, NY: Oxford University Press; 2009:211-243.
44. Leppert W.The role of methadone in cancer pain treatment-a review. Intl J Clin Pract. 2009;63 (7): 1095-1109.
45. Krantz MJ,Martin J,Stimmel B,Mehta D,Haigney MCP.QTc interval screening in methadone treatment.Ann Int Med. 2009;150 (6): 387-395.
46. Cleary JF.The pharmacologic management of cancer pain.J Pall Med. 2007;10 (6): 1369-1394.
47. Gagnon B,Abdulaziz A,Schrier G.Methadone in the treatment of neuropathic pain.Pain Res Manag. 2003;8 (3): 149-154.
48. Morley JS,Bridson J,Nash TP,Miles JB,White S,Makin MK.Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial.Palliat Med. 2003;17 (7): 576-587.
49. Moulin D,Palma D,Watling C,Schulz V.Methadone in the management of intractable neuropathic non cancer pain.Can J Neuro Sci. 2005;32 (3): 340-343.
50. Altier N,Dion D,Boulanger A,Choiniere M.Management of neuropathic pain with methadone: a review of 13 cases.Clin J Pain. 2005;21 (4): 364-369.
51. Mannino R,Coyne P,Swainey C,Hansen LA,Lyckholm L.Methadone for cancer-related neuropathic pain: a review of the literature.J Opioid Manag. 2006;2 (5): 269-276.
52. Legge J,Ball N,Elliott DP.The potential role of ketamine in hospice analgesia: a literature review.Consult Pharm. 2006;21 (1): 51-57.
53. Chung WJ.Successful use of ketamine infusion in the treatment of intractable cancer pain in an outpatient.J Pain Symptom Manage. 2007;33 (1): 2-5.
54. Bell RF,Eccleston C,Kalso EA.Ketamine as an adjuvant to opioids for cancer pain.Cochrane Database Syst Rev. 2003; (1)
55. Jost L,Roila F.Management of cancer pain: EMO clinical practice guidelines.Ann Oncol. 2010;21 (5 suppl): S257-S260.
56. Svendsen KB,Jensen TS,Bach FW.Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double-blind placebo controlled crossover trial.BMJ. 2004;329 (7460): 253-261.
57. Wallace JM.Update on pharmacotherapy guidelines for treatment of neuropathic pain.Curr Pain Headache Rep. 2007;11 (3): 208-214.
58. Nurmikko TJ,Serpell MG,Hoggart B,Toomey PJ,Morlion BJ,Haines D.Sativex successfully treats neuropathic pain characterized by allodynia: a randomized, double-blind, placebo-controlled clinical trial.Pain. 2007;133 (1-3): 210-220.
59. Dray A,Perkins MNPharmacology of Pain. Beaulieu PLussier DPorreca FDickenson AH, ed. Seattle, WA: IASP Press; 2010:383-401.